WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,119,006 | -29.8% | 522,900 | 0.0% | 0.01% | -22.2% |
Q2 2023 | $1,594,845 | +17.3% | 522,900 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $1,359,540 | +26.8% | 522,900 | 0.0% | 0.01% | +80.0% |
Q4 2022 | $1,071,945 | -54.5% | 522,900 | 0.0% | 0.01% | -64.3% |
Q3 2022 | $2,358,000 | +7.7% | 522,900 | -2.3% | 0.01% | -58.8% |
Q2 2022 | $2,189,000 | – | 535,160 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 589,102 | $1,260,678 | 25.95% |
MPM ASSET MANAGEMENT LLC | 4,284,172 | $9,168,128 | 4.91% |
MPM BioImpact LLC | 2,388,011 | $5,110,344 | 1.36% |
RA Capital Management | 6,144,881 | $13,150,045 | 0.26% |
PFM Health Sciences, LP | 2,558,282 | $5,474,723 | 0.26% |
SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,341,373 | 0.24% |
Rubric Capital Management LP | 1,935,357 | $4,141,664 | 0.16% |
Laurion Capital Management LP | 522,900 | $1,119,006 | 0.01% |
Alyeska Investment Group, L.P. | 397,808 | $851,309 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 95,511 | $204,394 | 0.01% |